Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease PR Newswire LAVAL, QC, May 31, 2023 Cover Your Bases Campaign Kicks Off Oral Health Month with...
SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION PR Newswire LAVAL, QC, Oct...
Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022 PR Newswire LAVAL, QC, Oct. 5, 2022 CMS Issues New Clarification...
SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY PR Newswire LAVAL, QC, Oct. 3, 2022 Centers for Medicare & Medicaid Services (CMS...
Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations PR Newswire LAVAL, Quebec, Sept. 28, 2022 LAVAL, Quebec, Sept. 28, 2022 /PRNewswire/ -- Bausch...
Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations PR Newswire LAVAL, QC, Sept. 14, 2022 LAVAL, QC, Sept. 14, 2022 /PRNewswire/ -- Bausch Health...
Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin PR Newswire LAVAL, QC, Sept. 9, 2022 LAVAL, QC, Sept. 9, 2022 /PRNewswire/ -- Bausch Health...
Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations PR Newswire LAVAL, Quebec, Sept. 8, 2022 LAVAL, Quebec, Sept. 8, 2022 /PRNewswire/ -- Bausch...
Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes PR Newswire LAVAL...
Bausch Health Continuing Process Toward Separating Bausch + Lomb PR Newswire LAVAL, QC, Aug. 22, 2022 LAVAL, QC, Aug. 22, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.51 | -4.39276485788 | 11.61 | 11.7 | 10.92 | 282811 | 11.24849866 | CS |
| 4 | -0.26 | -2.28873239437 | 11.36 | 13.74 | 10.92 | 343184 | 12.5138542 | CS |
| 12 | 3.2 | 40.5063291139 | 7.9 | 13.74 | 7.9 | 359712 | 11.16615393 | CS |
| 26 | 2.39 | 27.4397244546 | 8.71 | 13.74 | 5.45 | 379650 | 9.74268274 | CS |
| 52 | 1.73 | 18.4631803629 | 9.37 | 15.43 | 5.45 | 365527 | 10.57021098 | CS |
| 156 | -21.3 | -65.7407407407 | 32.4 | 36.26 | 5.1 | 652236 | 12.58536508 | CS |
| 260 | -25.64 | -69.7876973326 | 36.74 | 43.97 | 5.1 | 639014 | 19.44327959 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
